Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma

被引：21

作者：

Murphy, N. C. ^{[1
,2
]}

Scarlett, C. J. ^{[1
]}

Kench, J. G. ^{[1
]}

Sum, E. Y. M. ^{[3
]}

Segara, D. ^{[1
]}

Colvin, E. K. ^{[1
]}

Susanto, J. ^{[1
]}

Cosman, P. H. ^{[1
]}

Lee, C. -S ^{[2
,4
]}

Musgrove, E. A. ^{[1
]}

Sutherland, R. L. ^{[1
]}

Lindeman, G. J.

Henshall, S. M. ^{[1
]}

Visvader, J. E. ^{[3
]}

Biankin, A. V. ^{[1
,5
]}

机构：

[1] Garvan Inst Med Res, Canc Res Program, Pancreatic Canc Res Grp, Darlinghurst, NSW 2010, Australia

[2] Royal Prince Alfred Hosp, Dept Pathol Anat, Sydney, NSW 2050, Australia

[3] Westmead Hosp, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia

[4] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia

[5] Bankstown Hosp, Div Surg, Sydney, NSW 2200, Australia

来源：

BRITISH JOURNAL OF CANCER | 2008年 / 98卷 / 03期

基金：

英国医学研究理事会;

关键词：

LMO4; prognosis; outcome; pancreatic cancer; surgical resection; therapeutic response;

D O I：

10.1038/sj.bjc.6604177

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Identification of a biomarker of prognosis and response to therapy that can be assessed preoperatively would significantly improve overall outcomes for patients with pancreatic cancer. In this study, patients whose tumours exhibited high LMO4 expression had a significant survival advantage following operative resection, whereas the survival of those patients whose tumours had low or no LMO4 expression was not significantly different when resection was compared with operative biopsy alone.

引用

页码：537 / 541

页数：5

共 50 条

[41] Risk Factors and Outcome of Patients With Pancreatic Ductal Adenocarcinoma and Thromboembolism
Eurola, A.
Mattila, N.
Lassila, R.
Mustonen, H.
Haglund, C.
Seppanen, H.
PANCREAS, 2019, 48 (10) : 1424 - 1424
[42] Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
Ansari, D.
Bauden, M.
Bergstrom, S.
Rylance, R.
Marko-Varga, G.
Andersson, R.
BRITISH JOURNAL OF SURGERY, 2017, 104 (05) : 600 - 607
[43] The Influence of Patients' Age on the Outcome of Treatment for Pancreatic Ductal Adenocarcinoma
Malik, Abdullah K.
Lamarca, Angela
Siriwardena, Ajith Kumar
O'Reilly, Derek
Deshpande, Rahul
Satyadas, Thomas
Jamdar, Saurabh
Sheen, Aali
McNamara, Mairead
Hubner, Richard
Valle, Juan
De Liguori Carino, Nicola
PANCREAS, 2020, 49 (02) : 201 - 207
[44] Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma
Shutaro Hori
Kazuaki Shimada
Yoshinori Ino
Seiji Oguro
Minoru Esaki
Satoshi Nara
Yoji Kishi
Tomoo Kosuge
Yukinori Hattori
Aoi Sukeda
Yuko Kitagawa
Yae Kanai
Nobuyoshi Hiraoka
Virchows Archiv, 2016, 469 : 621 - 634
[45] Macroscopic features predict outcome in patients with pancreatic ductal adenocarcinoma
Hori, Shutaro
Shimada, Kazuaki
Ino, Yoshinori
Oguro, Seiji
Esaki, Minoru
Nara, Satoshi
Kishi, Yoji
Kosuge, Tomoo
Hattori, Yukinori
Sukeda, Aoi
Kitagawa, Yuko
Kanai, Yae
Hiraoka, Nobuyoshi
VIRCHOWS ARCHIV, 2016, 469 (06) : 621 - 634
[46] Improvement in Treatment and Outcome of Pancreatic Ductal Adenocarcinoma in North China
Yong Chen
JiHui Hao
WeiDong Ma
Yong Tang
ChunTao Gao
XiShan Hao
Journal of Gastrointestinal Surgery, 2011, 15 : 1026 - 1034
[47] REGULATION OF EXCESSIVE ALCOHOL CONSUMPTION BY THE TRANSCRIPTIONAL COFACTOR LMO4
Maiya, R.
Pomrenze, M. B.
Tran, T.
Tiwari, G. N.
Mayfield, R. D.
Messing, R. O.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 : 10 - 10
[48] Requirement for Lmo4 in the vestibular morphogenesis of mouse inner ear
Deng, Min
Pan, Ling
Xie, Xiaoling
Gan, Lin
DEVELOPMENTAL BIOLOGY, 2010, 338 (01) : 38 - 49
[49] LMO4 Is Essential for Paraventricular Hypothalamic Neuronal Activity and Calcium Channel Expression to Prevent Hyperphagia
Zaman, Tariq
Zhou, Xun
Pandey, Nihar R.
Qin, Zhaohong
Keyhanian, Kianoosh
Wen, Kendall
Courtney, Ryan D.
Stewart, Alexandre F. R.
Chen, Hsiao-Huei
JOURNAL OF NEUROSCIENCE, 2014, 34 (01): : 140 - 148
[50] Pancreatic ductal adenocarcinoma
Gallmeier, E.
Gress, T. M.
INTERNIST, 2018, 59 (08): : 805 - 822

← 1 2 3 4 5 →